Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA: GERM)

Latest news for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA:GERM)

Healthcare

Industrials

Other

Under normal circumstances, the Fund invests at least 80 percent of its net assets (plus borrowings for investment purposes) in U.S.-listed equity securities or American Depositary Receipts (ADRs) of Treatments, Testing and Advancements Companies (as defined below). In general, the Index seeks to be comprised of companies: i) performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or ii) engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients.

Alnylam Pharmaceuticals Inc Common Stock Usd 0.01

Laboratory Corporation Of America Holdings

Quest Diagnostics Inc

Biontech Se

Moderna therapeutics

Vaxcyte Inc

Immunitybio Inc.

Bio-Rad Laboratories-A Common Stock

Zai Lab Ltd-adr

Immunocore Holdings Ltd(180 Day Lock Up)

Amplify Treatments Testing and Advancements ETF

Biotech

Earnings

Long Ideas

News

Sector ETFs

Short Ideas

Health Care

Technicals

Contracts

Trading Ideas

ETFs

General

ETFMG Treatments Testing and Advancements ETF

GERM

MRNA

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground.

Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play

BNTX

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) 

First Vaccine ETF Should See Halcyon Days Ahead

New ETFs

AMZN

GILD

NFLX

NVDA

VIRS

It was just a week ago that the first exchange-traded fund dedicated to vaccine developers, plenty engaged in the fight against the coronavirus, came to market. Now, that fund has company.

What Happened: The Pacer BioThreat Strategy ETF (NYSE:VIRS) debuted Thursday as the latest addition to the beat-the-coronavirus-ETF fray.

VIRS Makes Pandemic, Vaccine ETF Competition More Interesting

Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF

German American Bancorp, Inc. - Common Stock

German American Bancorp Inc

Biomarin Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) has outperformed the market over the past 20 years by 6.65% on an annualized basis producing an average annual return of 15.22%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.31 billion. 
Buying $1000 In BMRN: If an investor had bought $1000 of BMRN stock 20 years ago, it would be worth $16,360.00 today based on a price of $85.89 for BMRN at the time of writing.
<h3>Biomarin Pharmaceutical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721165646_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMRN

$1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today

Mexico's America Movil Reports Q2 Net Loss Of 1.09 Billion Pesos; Reports Q2 Revenue Of 205.52 Billion Pesos

ESTA

Establishment Labs Holdings Says FDA To Begin PMA Preapproval Inspection Of Co's Manufacturing Facility For Motiva Implants On July 22

Spirit Airlines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) shares are trading lower after the company announced soft second-quarter preliminary <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39672167/u-s-airlines-to-take-flight-in-q2-analyst-predicts-strong-results-10-operating-marg">revenue estimates Tuesday. </a>
The Details: Spirit Airlines <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001498710/000149871024000179/save-20240716.htm">estimated total revenue</a> for the second quarter of 2024 to be approximately $1.28 billion, lower than previously expected primarily due to lower-than-expected non-ticket revenue.
Read Next: <a href="https://www.benzinga.com/news/24/07/39777940/whats-going-on-with-upstart-stock">What&#8217;s Going On With Upstart Stock?</a>
The company said non-ticket revenue for the quarter underperformed its initial estimate and attributed the underperformance to incremental pressure on ancillary pricing due to changes in the competitive marketplace. The company estimates non-ticket revenue per passenger segment will be about $64 for the second quarter of 2024, several dollars lower than previously anticipated.
The company said it had anticipated significant pressure on leisure ticket yields throughout the second quarter and continuing into the third quarter due to large industry capacity increases. Estimated ticket revenue per segment for the second quarter was in-line with the company's previous expectations.
SAVE Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Spirit Airlines shares are down 5.70% after-hours at $2.98 at the time of publication Tuesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39776035/solar-stocks-tumble-following-failed-assassination-of-trump-whats-going-on">Solar Stocks Tumble Following Failed Assassination Of Trump: What&#8217;s Going On?</a></li>
</ul>
Photo: Courtesy Spirit

After-Hours Center

Movers

SAVE

Spirit Airlines Stock Falls On Soft Preliminary Q2 Revenue Estimates

Built at NASA&#39;s Michoud Assembly Facility (MAF), the core stage is designed to send the Artemis II crew to lunar orbit for the first time in 50 years.
The Boeing-built rocket stage, which is the largest component of the Artemis II mission, will be loaded onto the Pegasus barge and transported 900 miles to NASA&#39;s Kennedy Space Center.&nbsp;
This integration is a crucial step in preparation for the Artemis II launch, scheduled for 2025.
&nbsp;

Boeing Says It Provided NASA With Second Core Stage Of Space Launch System Rocket

Canopy Growth Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares continued to move higher Tuesday after gaining more than 9% in Monday's session. Here's a look at <a href="https://www.benzinga.com/markets/cannabis/24/07/39773667/leaked-documents-czech-republic-plans-to-set-up-legal-recreational-cannabis-market">what you need to know.</a> 
What To Know: Canopy Growth stock popped Monday around the same time former President Donald Trump selected Sen. J.D. Vance (R-Ohio) as his vice-presidential running-mate. Ohio <a href="https://www.benzinga.com/markets/cannabis/23/11/35664155/ohio-legalizes-cannabis-and-overwhelmingly-approves-abortion-rights" target="_blank" rel="noreferrer noopener">legalized adult-use cannabis</a> in November 2023.
According to a Marijuana Moment <a href="https://www.marijuanamoment.net/where-trumps-vice-presidential-running-mate-j-d-vance-stands-on-marijuana/">report</a>, Vance believes states should set their own cannabis laws. He&#8217;s also suggested that he's against incarcerating individuals for low-level possession.
Vance voted against the Secure and Fair Enforcement Regulation (SAFER) Banking Act when it <a href="https://www.benzinga.com/markets/cannabis/23/09/34929327/breaking-senate-committee-approves-cannabis-banking-reform-in-historic-vote" target="_blank" rel="noreferrer noopener">was approved</a> in September 2023, noting that &#8220;the bill was crafted in such a way that actually would have opened up access to banking resources for fentanyl traffickers and others.&#8221; However, Vance left the door open to approving a revised bill in the future.
&#8220;If the legislation is better, I&#8217;d be more likely to support it,&#8221; he said at the time.
Read Next: <a href="https://www.benzinga.com/news/24/07/39776035/solar-stocks-tumble-following-failed-assassination-of-trump-whats-going-on">Solar Stocks Tumble Following Failed Assassination Of Trump: What&#8217;s Going On?</a>
What Else: The Czech government is reportedly pursuing a full commercial adult-use cannabis market as part of its Cannabis Management Act, according to a <a href="https://businessofcannabis.com/czech-republic-will-pursue-full-adult-use-commercial-cannabis-market-leaked-documents-suggest/">report </a>released Monday from Business of Cannabis. Canopy Growth currently serves the medical marijuana market in the Czech Republic.
Canopy Growth still faces several headwinds, including the uncertain regulatory environment in the U.S., and the company has yet to become profitable. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Canopy Growth shares are trading below the stock&#8217;s 50-day moving average of $8.02. It&#8217;s also worth noting that approximately 17.5% of Canopy&#8217;s float is currently being sold short. 
<h2 class="wp-block-heading">Will CGC Stock Go Up?</h2>
When trying to assess whether or not Canopy Growth will trade higher from current levels, it's a good idea to take a look at analyst forecasts. 
Wall Street analysts have an average 12-month price target of $2 on Canopy Growth. One analyst has a negative rating on Canopy Growth&#8217;s stock. 
In the last month, one analyst has adjusted price targets. Here's a look at recent price target changes <a href="https://www.benzinga.com/quote/CGC/analyst-ratings">[Analyst Ratings]</a>. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Canopy Growth have performed in recent history. 
Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Canopy Growth is 80.49% up year-to-date. The average analyst price target suggests the stock could have further downside ahead.
For a broad overview of everything you need to know about Canopy Growth, visit <a href="https://www.benzinga.com/quote/CGC">here</a>. If you want to go above and beyond, there's no better tool to help you do just that than <a href="https://pro.benzinga.com/">Benzinga Pro</a>. Start your free trial today.
CGC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Canopy Growth shares ended Tuesday session 3.08% higher at $7.36. 
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39777940/whats-going-on-with-upstart-stock">What&#8217;s Going On With Upstart Stock?</a></li>
</ul>
Image: Nicky from Pixabay

Cannabis

What Happened With Canopy Growth Stock Today?

<a href="https://www.washingtonpost.com/politics/2024/07/16/biden-supreme-court-reforms/">https://www.washingtonpost.com/politics/2024/07/16/biden-supreme-court-reforms/</a>
<a href="https://www.washingtonpost.com/elections/candidates/joe-biden-2024/?itid=lk_inline_manual_2">President Biden</a> is finalizing plans to endorse major changes to the Supreme Court in the coming weeks, including proposals for legislation to establish term limits for the justices and an enforceable ethics code, according to two people briefed on the plans.
He is also weighing whether to call for a constitutional amendment to eliminate broad immunity for presidents and other constitutional officeholders, the people said, speaking on the condition of anonymity to discuss private deliberations.
The announcement would mark a major shift for Biden, a former chair of the Senate Judiciary Committee, who has long resisted calls to reform the high court. They potential changes come in response to growing outrage among his supporters about recent ethics scandals surrounding Justice Clarence Thomas and decisions by the new court majority that have changed legal precedent on issues including <a href="https://www.washingtonpost.com/abortion/?itid=lk_inline_manual_5">abortion</a> and federal regulatory powers.
Biden previewed the shift in a Zoom call Saturday with the Congressional Progressive Caucus.
"I'm going to need your help on the Supreme Court, because I'm about to come out — I don't want to prematurely announce it — but I'm about to come out with a major initiative on limiting the court … I've been working with constitutional scholars for the last three months, and I need some help," Biden said, according to a transcript of the call obtained by The Washington Post.
Many if not all of the changes would likely need congressional approval. The details of Biden's considered policies have not been disclosed. A White House spokesperson declined to comment.
Biden's private remarks about his high court plans came more than two weeks after his wobbly, confused performance at a June 27 debate with <a href="https://www.washingtonpost.com/donald-trump/?itid=lk_inline_manual_12">Donald Trump</a>, which prompted calls from some Democrats for him to step aside as the party's presidential nominee. Among those who have rallied to his side are many liberals who strongly support calls to remake the court.
Four days after that debate, the Supreme Court ruled Trump <a href="https://www.washingtonpost.com/politics/2024/07/01/trump-immunity-supreme-court-ruling/?itid=ap_anne.marimow&amp;itid=lk_inline_manual_14">was immune from prosecution</a> for official acts during his first term in office. Less than an hour later, Biden called Laurence Tribe, a constitutional law professor at Harvard Law School, to discuss the ruling and the arguments for and against reforming the court.
"This decision today has continued the court's attack in recent years on a wide range of long-established legal principles in our nation, from gutting voting rights and civil rights to taking away a woman's right to choose to today's decision that undermines the rule of law of this nation," Biden said in public remarks later that day.
The next week, Biden called Tribe again and the two discussed <a href="https://www.theguardian.com/commentisfree/article/2024/jul/08/us-supreme-court-presidential-immunity">a Guardian opinion piece he wrote</a> endorsing reforms to the Supreme Court. Among the options they discussed: term limits, an enforceable ethics code and the constitutional amendment to address presidential immunity.
Tribe confirmed he spoke with Biden but declined to comment on their discussion.
During the 2020 presidential race, Biden rebuffed calls from liberals who advocated expanding the court but promised he would create a commission to study potential changes. He followed through on that promise after being elected, and the commission issued a 294-report to the president. Biden has not acted on the commission's report since they approved it in December 2021.
Approval ratings of the Supreme Court have dropped precipitously in recent years and Biden finds himself trying to resuscitate a flagging presidential campaign after the politically disastrous debate.
Since he was elected, the Supreme Court <a href="https://www.washingtonpost.com/politics/2024/07/02/supreme-court-2024-conservative-power-trump/?itid=ap_anne.marimow&amp;itid=lk_inline_manual_24">has veered sharply to the right</a> — overturning Roe v. Wade, ended affirmative action in college admissions, weakened federal agencies' power by overturning a 40-year decision and struck down Biden's student loan forgiveness program. Biden condemned the court's recent ruling on presidential immunity, arguing on July 1 that it should motivate Americans to vote for his reelection.
"Each of us is equal before the law. No one — no one is above the law, not even the president of the United States," Biden said in a White House address. "With today's Supreme Court decision on presidential immunity, that fundamentally changed."
Eight Democratic senators have <a href="https://www.congress.gov/bill/118th-congress/senate-bill/3096/cosponsors">co-sponsored a bill</a> that would establish 18-year terms for Supreme Court justices, with a new justice appointed every two years. The nine most recently appointed justices would sit for appellate jurisdiction cases, while others would be able to hear original jurisdiction cases or to step in as a substitute if one of the most recent nine is conflicted or cannot hear a case for another reason.
The legislation was introduced by Sen. Sheldon Whitehouse (D-R.I.), but it has been co-sponsored by Cory Booker (D-N.J.), Richard Blumenthal (D-Conn.), Alex Padilla (D-Calif.), Jeff Merkley (D-Ore.), Peter Welch (D-Vt.), Brian Schatz (D-Hawaii) and Kirsten Gillibrand (D-N.Y.).
Democrats have offered other legislation to deal with ethics concerns about the high court, including <a href="https://www.warren.senate.gov/newsroom/press-releases/senator-warren-representative-jayapal-reintroduce-the-judicial-ethics-and-anti-corruption-act">a bill</a> by Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash) that caps the gifts judges can receive, requires the Supreme Court to follow the judicial code of conduct and requires justices to write written recusal decisions upon request from litigants, among other changes.

Macro Economic Events

Politics

Economics

Federal Reserve

'Biden Set To Announce Support For Major Supreme Court Changes; Plans Include Proposals For Legislation To Establish Term Limits For The Justices And An Enforceable Ethics Code' - Washington Post

Gates Industrial will replace Abercrombie &amp; Fitch in the S&amp;P SmallCap 600 effective prior to the opening of trading on Monday, July 22.

GTES

Gates Industrial To Join S&P SmallCap 600

- Bloomberg Businessweek Interview

Global

Former President Donald Trump Says New Tariffs For China Between 60%-100%, Would Impose A 10% Tariff On Imports From Other Countries

S&amp;P SmallCap 600 constituent Abercrombie &amp; Fitch will replace Equitrans Midstream&nbsp; in the S&amp;P MidCap 400, effective prior to the opening of trading on Monday, July 22.&nbsp;

ETRN

Abercrombie & Fitch Set To Join S&P MidCap 400

GOOG

GOOGL

SNAP

Former President Donald Trump Wants To Bring Corporate Tax Rate To As Low As 15%, And He No Longer Plans To Ban TikTok

Former President Donald Trump Says Fed Should Abstain From Cutting Rates Before November Election

Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.30 by 56.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $246.276 million which beat the analyst consensus estimate of $235.554 million by 4.55 percent. This is a 13.36 percent increase over sales of $217.257 million the same period last year.

Earnings Beats

FULT

Fulton Financial Q2 2024 Sales $246.276M Beat $235.554M Estimate

Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.30 by 56.67 percent. This is unchanged from the same period last year.

Fulton Financial Q2 2024 Adj EPS $0.47 Beats $0.30 Estimate

Former President Donald Trump Says He'd Consider Jamie Dimon, CEO Of JPMorgan To Serve As Secretary Of The Department Of Treasury

Former President Donald Trump Says "Trumponomics" Equates To "Low Interest Rates And Taxes."; Says He'll Allow Jerome Powell To Serve Out His Term As Chair Of The Federal Reserve

Aris Mining Corporation (Aris Mining or the Company) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#TSX">ARIS</a>) (NYSE-A: ARMN) announces gold production of 99,983 ounces for the first half of 2024 (H1 2024), with 88,613 ounces from Segovia and 11,370 ounces from the Marmato Upper Mine. In the same period in 2023, the Company produced 104,906 ounces of gold, including 94,395 ounces from Segovia and 10,511 ounces from the Marmato Upper Mine. As the Segovia mine plan progresses to higher-grade zones the Company is on track to meet the lower end of its full-year production guidance of 220,000 to 240,000 ounces.
Neil Woodyer, CEO of Aris Mining, commented &quot;Our Segovia processing facilities performed well during Q2, consistently achieving over 2,000 tonnes per day (tpd) of throughput. As previously disclosed, the Segovia Operations were moving through relatively low-grade zones in the production schedule, and higher-grade zones are now being mined.

ARMN

Aris Mining Reports H1 2024 Production, Provides Expansion Projects Update; On Track To Meet The Lower End Of Its Full-Year Production Guidance Of 220K-240K Ounces

Conduit Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares traded higher by as much as 57% to $0.37 during Tuesday&#8217;s session before closing near flat after the company announced it received patent approval for its lead asset <a href="https://www.benzinga.com/pressreleases/24/07/g39789803/conduit-pharmaceuticals-receives-patent-approval-for-its-lead-asset-targeting-autoimmune-diseases">targeting autoimmune diseases</a>.
The company said this achievement allowed Conduit to participate in the Patent Prosecution Highway (PPH), expediting patent examination in key markets like the U.S., Europe and Japan. 
Conduit also said the patent, numbered 2022384750, enhanced the likelihood of approvals in other major jurisdictions, providing up to 20 years of protection crucial for drug products.
Conduit&#8217;s research also identified cocrystals of AZD1656, leveraging solid-form technology to enhance patent protection and strategic value in pharmaceutical markets. CEO Dr. David Tapolczay emphasized the patent&#8217;s significance in bolstering its intellectual property portfolio and potential for future partnerships.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/07/39800635/why-air-products-and-chemicals-shares-are-surging-today">Why Air Products and Chemicals Shares Are Surging Today</a>
<h1 class="wp-block-heading">How To Buy CDT Stock</h1>
By now you're likely curious about how to participate in the market for Conduit Pharmaceuticals — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. There is a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow a person to buy &#8220;fractional shares,&#8221; which allows ownership of portions of stock without buying an entire share. For example, some stock, such as Berkshire Hathaway or Amazon.com, can cost thousands of dollars to own just one share. However, if a person only wants to invest a fraction of that, brokerages will allow it.
In the the case of Conduit Pharmaceuticals, which is trading at $0.31 as of publishing time, $100 would buy 322.58 shares of stock.
If looking to bet against a company, the process is more complex. A person will need access to an options trading platform or a broker who will allow ‘going short' a share of stock by lending the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if a broker allows a person to trade options, either buy a put option or sell a call option at a strike price above where shares are currently trading — either way it allows a profit off of the share price decline.
CDT Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Conduit Pharmaceuticals has a 52-week high of $12.89 and a 52-week low of $0.21. Shares closed out Tuesday up 4.63% at 25 cents.
Photo: <a href="https://pixabay.com/users/pexels-2286921/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1853262">Pexels</a> from <a href="https://pixabay.com//?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=1853262">Pixabay</a>

What Happened With Conduit Pharmaceuticals (CDT) Stock Today?

Microsoft Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Activision has officially confirmed the beta dates for Call of Duty: Black Ops 6, marking a significant <a href="https://www.benzinga.com/topic/call-of-duty">milestone for the franchise. </a>
For the first time, the beta will be available on all platforms simultaneously, providing a unified experience for players worldwide. 
The beta, announced during the Call of Duty podcast on YouTube, as <a href="https://www.ign.com/articles/call-of-duty-black-ops-6-beta-dates-confirmed">reported</a> by IGN, will roll out in two phases:
<ul>
<li>Early Access: August 30 &#8211; September 4</li>
<li>Open Beta: September 6 &#8211; September 9</li>
</ul>
See Also: <a href="https://www.benzinga.com/general/gaming/24/06/39257159/call-of-duty-black-ops-6-requires-constant-internet-connection-on-consoles-for-first-time">Call Of Duty Black Ops 6 Requires Constant Internet Connection On Consoles For First Time</a> 
Historically, Call of Duty betas have been exclusive to Sony Group Corp.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) PlayStation platforms. However, this time, early access will be granted to Game Pass subscribers and those who pre-order Black Ops 6. 
<h3 class="wp-block-heading">A Glimpse Into Black Ops 6</h3>
First revealed in May after months of speculation, Black Ops 6 is the latest installment in the long-running series developed by Treyarch. 
Activision provided an in-depth look at the game in June, detailing the multiplayer modes, the highly anticipated Zombies mode, and a campaign set in the 1990s. True to the Black Ops sub-series, the game promises a storyline filled with paranoia, where players &#8220;never sure who to trust, and what is real.&#8221;
<h3 class="wp-block-heading">Addressing Game Pass Changes</h3>
Black Ops 6&#8217;s announcement coincides with recent adjustments to Xbox Game Pass pricing. The game will be available on Game Pass at launch for Xbox Game Pass Ultimate, PC Game Pass, and Xbox Game Pass for Console. 
This change follows Microsoft&#8217;s $69 billion acquisition of Activision Blizzard, making Black Ops 6 the first mainline Call of Duty game to launch directly onto the subscription service.
<h3 class="wp-block-heading">Scorestreak System Changes Spark Debate</h3>
One of the most talked-about features of Black Ops 6 is the revised scorestreak system. Treyarch has confirmed that the game will ditch the ‘streak looping' mechanic, where players could earn scorestreaks multiple times within the same life. Instead, the game reverts to a more traditional system where scores reset upon death.
Matt Scronce, Treyarch's associate director of design, explained the reasoning behind this change during the inaugural episode of the COD POD: "We're going back to a traditional scorestreak system. Score will reset on death. Right now, scorestreaks do not loop.&#8221; 
He added: &#8220;That was something we talked about quite a bit. Really the goal there is we want to reward players in a single life fairly, with high-end rewards, or low-end depending on your selection. But we really want to avoid scorestreak spam. That's something I personally just really don't like. I know a lot of players don't like it."
This shift has ignited a debate within the Call of Duty community. High-skill players argue that the absence of looping streaks limits their ability to dominate matches, as they can no longer earn multiple high-end rewards without dying. 
On the other hand, many players and developers believe this change will reduce scorestreak spam, making the gameplay experience more enjoyable for the majority.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/06/39277761/activision-confirms-call-of-duty-black-ops-6-wont-require-massive-300-gb-download">Activision Confirms Call Of Duty: Black Ops 6 Won&#8217;t Require Massive 300 GB Download</a></li>
</ul>

Gaming

MSFT

Sony Group Corporation American Depositary Shares

SONY

Black Ops 6: First Multi-Platform Beta In Franchise History — All You Need To Know

LM Funding America, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) ("LM Funding" or the "Company"), a cryptocurrency mining and technology-based specialty finance company, today provided a preliminary, unaudited Bitcoin mining update for the month ended June 30, 2024.
<figure class="table"> 
<table>
<tbody>
<tr>
<td> Metrics &#x2A;</td>
<td> One Month January 31, 2024</td>
<td> One Month February 29, 2024</td>
<td> One Month March 31, 2024</td>
<td> One Month April 30, 2024</td>
<td> One Month May 31, 2024</td>
<td> One Month June 30, 2024</td>
<td> Six Months June 30, 2024</td>
</tr>
<tr>
<td>Bitcoin Beginning Balance</td>
<td>95.1</td>
<td>126.8</td>
<td>153.6</td>
<td>163.4</td>
<td>155.1</td>
<td>163.1</td>
<td>95.1</td>
</tr>
<tr>
<td>Bitcoin Mined, net</td>
<td>31.7</td>
<td>26.8</td>
<td>27.9</td>
<td>24.7</td>
<td>14.0</td>
<td>5.4</td>
<td>130.5</td>
</tr>
<tr>
<td>Bitcoin Sold</td>
<td>-</td>
<td>-</td>
<td>(18.0)</td>
<td>(33.0)</td>
<td>(6.0)</td>
<td>(8.0)</td>
<td>(65.0)</td>
</tr>
<tr>
<td>Service Fee</td>
<td>-</td>
<td>-</td>
<td>(0.1)</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>(0.1)</td>
</tr>
<tr>
<td>Bitcoin Holdings</td>
<td>126.8</td>
<td>153.6</td>
<td>163.4</td>
<td>155.1</td>
<td>163.1</td>
<td>160.5</td>
<td>160.5</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Approximate Miners Deployed at Month End</td>
<td>5,950</td>
<td>5,940</td>
<td>5,940</td>
<td>5,880</td>
<td>5,510</td>
<td>1,878</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Approximate Miners In-Transit at Month End</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>370</td>
<td>4,002</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Approximate Potential Hash Rate at Month End (PH/s)</td>
<td>615</td>
<td>614</td>
<td>614</td>
<td>639</td>
<td>639</td>
<td>639</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
&#x2A;Unaudited
Effective July 12, 2024, approximately 2,900 mining machines ("Miners") were installed and deployed at a site in Oklahoma owned and operated by Arthur Mining under our previously announced strategic collaboration with Arthur Mining, while an additional 1,000 Miners that were active at June month-end were moved in July from a different Oklahoma site to a warehouse for redeployment.
Bruce M. Rodgers, Chairman and CEO of LM Funding, stated, "Our mining operations for June 2024 reflect the timely ending of several unfavorable hosting contracts as of May 31, 2024, which allows us to reposition our Miners to lower cost sites. We were able to redeploy and energize approximately 3,000 Miners to the Arthur Oklahoma hosting site in July 2024 and currently anticipate that the remaining Miners will be redeployed to other lower-cost hosting sites over approximately the next four months. In addition, we have entered into a non-binding term sheet with a potential lender regarding a secured non-convertible loan facility of up to $5.0 million that would be used to acquire additional Miners, and if such loan is consummated, it would have a maturity date of 2 years from the closing of the loan."
The Company estimates that the value of its 160.5 Bitcoin holdings on June 30, 2024, was approximately $10.2 million, based on an estimated June 15, 2024, BTC price of $63,750. However, under the new accounting standards effective for 2024, the Company will revalue its Bitcoin holdings to the quarter-end BTC market value each quarter.

LMFA

LM Funding America Provides Monthly Operational And Bitcoin Mining Update; Estimates That The Value Of Its 160.5 Bitcoin Holdings On June 30, 2024, Was ~$10.2M

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF

News

Latest news for Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA:GERM)

Thursday, May 06, 2021

Tuesday, November 10, 2020

Monday, June 29, 2020

Friday, June 19, 2020